Trials / Unknown
UnknownNCT02818309
Lesogaberan in Chinese Patients With Refractory Reflux Symptoms
Efficacy and Safety of Lesogaberan (AZD3355) in Chinese Patients With Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy: a Randomized Placebo-controlled Trial
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Lesogaberan may be used in Chinese GERD patients with partial response to PPI.
Detailed description
To test the efficacy and safety of lesogaberan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lesogaberan | 120 mg bid |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-11-01
- Completion
- 2017-12-01
- First posted
- 2016-06-29
- Last updated
- 2016-06-29
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02818309. Inclusion in this directory is not an endorsement.